U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Fujian Guangyang Egg Industry Company Limited - 594964 - 02/04/2021
  1. Warning Letters

CLOSEOUT LETTER

Fujian Guangyang Egg Industry Company Limited MARCS-CMS 594964 —

Product:
Food & Beverages
Recipient:
Recipient Name
Mr. Jie Yu
Recipient Title
Chairman
Fujian Guangyang Egg Industry Company Limited

Hongxing Village
Jinyang Town
Fuqing Shi
Fuzhou Shi
Fujian Sheng, 350303
China

Issuing Office:
Center for Food Safety and Applied Nutrition

United States

Dear: Mr. Yu:

The Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our Warning Letter 594964, issued December 26, 2019. Based on our evaluation, it appears you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Robyn R. Jones
Division of Enforcement
Office of Compliance
Center for Food Safety and Applied Nutrition

 
Back to Top